Literature DB >> 29903763

A novel type of NPM1 mutation characterized by multiple internal tandem repeats in a case of cytogenetically normal acute myeloid leukemia.

Nicolas Duployez1,2, Lydia Chebrek3, Nathalie Helevaut3,2, Elise Fournier2,4, Maxime Bemba5, Aurélie Caillault3, Sandrine Geffroy3,2, Claude Preudhomme3,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29903763      PMCID： PMC6269301          DOI： 10.3324/haematol.2018.190959

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help.

Authors:  Brunangelo Falini; Maria Paola Martelli; Stefano A Pileri; Cristina Mecucci
Journal:  Haematologica       Date:  2010-04       Impact factor: 9.941

2.  Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.

Authors:  Jay L Patel; Jonathan A Schumacher; Kimberly Frizzell; Shelly Sorrells; Wei Shen; Adam Clayton; Rakhi Jattani; Todd W Kelley
Journal:  Leuk Res       Date:  2017-01-23       Impact factor: 3.156

3.  LocNES: a computational tool for locating classical NESs in CRM1 cargo proteins.

Authors:  Darui Xu; Kara Marquis; Jimin Pei; Szu-Chin Fu; Tolga Cağatay; Nick V Grishin; Yuh Min Chook
Journal:  Bioinformatics       Date:  2014-12-15       Impact factor: 6.937

4.  Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype.

Authors:  Nicolas Boissel; Aline Renneville; Valeria Biggio; Nathalie Philippe; Xavier Thomas; Jean-Michel Cayuela; Christine Terre; Isabelle Tigaud; Sylvie Castaigne; Emmanuel Raffoux; Stephane De Botton; Pierre Fenaux; Herve Dombret; Claude Preudhomme
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

5.  Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations.

Authors:  Konstanze Döhner; Richard F Schlenk; Marianne Habdank; Claudia Scholl; Frank G Rücker; Andrea Corbacioglu; Lars Bullinger; Stefan Fröhling; Hartmut Döhner
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

Review 6.  Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

Authors:  A Renneville; C Roumier; V Biggio; O Nibourel; N Boissel; P Fenaux; C Preudhomme
Journal:  Leukemia       Date:  2008-02-21       Impact factor: 11.528

Review 7.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

Review 8.  When the good go bad: Mutant NPM1 in acute myeloid leukemia.

Authors:  Preethi Kunchala; Sudhakiranmayi Kuravi; Roy Jensen; Joseph McGuirk; Ramesh Balusu
Journal:  Blood Rev       Date:  2017-11-04       Impact factor: 8.250

9.  Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia.

Authors:  Tamara Alpermann; Susanne Schnittger; Christiane Eder; Frank Dicker; Manja Meggendorfer; Wolfgang Kern; Christoph Schmid; Carlo Aul; Peter Staib; Clemens-Martin Wendtner; Norbert Schmitz; Claudia Haferlach; Torsten Haferlach
Journal:  Haematologica       Date:  2015-10-15       Impact factor: 11.047

10.  Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.

Authors:  Aline Renneville; Raouf Ben Abdelali; Sylvie Chevret; Olivier Nibourel; Meyling Cheok; Cécile Pautas; Rémy Duléry; Thomas Boyer; Jean-Michel Cayuela; Sandrine Hayette; Emmanuel Raffoux; Hassan Farhat; Nicolas Boissel; Christine Terre; Hervé Dombret; Sylvie Castaigne; Claude Preudhomme
Journal:  Oncotarget       Date:  2014-02-28
View more
  2 in total

1.  Up-regulation of EMT-related gene VCAN by NPM1 mutant-driven TGF-β/cPML signalling promotes leukemia cell invasion.

Authors:  Liyuan Yang; Lu Wang; Zailin Yang; Hongjun Jin; Qin Zou; Qian Zhan; Yuting Tang; Yao Tao; Li Lei; Yipei Jing; Xueke Jiang; Ling Zhang
Journal:  J Cancer       Date:  2019-10-21       Impact factor: 4.207

2.  Mutant NPM1-Regulated FTO-Mediated m6A Demethylation Promotes Leukemic Cell Survival via PDGFRB/ERK Signaling Axis.

Authors:  Qiaoling Xiao; Li Lei; Jun Ren; Meixi Peng; Yipei Jing; Xueke Jiang; Junpeng Huang; Yonghong Tao; Can Lin; Jing Yang; Minghui Sun; Lisha Tang; Xingyu Wei; Zailin Yang; Ling Zhang
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.